After receiving approval from the U.S. Food and Drug Administration (FDA) for its brain injury-related obesity treatment, Rhythm Pharmaceuticals Inc. (RYTM) shares surged 7.4% in pre-market trading.

老虎证券2026/03/20 10:49

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This major regulatory breakthrough has cleared the listing obstacles for the company's treatment product targeting hypothalamic obesity, significantly boosting investor confidence and directly reflected in the positive trend of its stock price.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

After receiving approval from the U.S. Food and Drug Administration (FDA) for its brain injury-related obesity treatment, Rhythm Pharmaceuticals Inc. (RYTM) shares surged 7.4% in pre-market trading.

You may also like

Crypto prices